Percy H. Carter - 06 Jun 2022 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Ariel Hurley, Attorney-in-Fact
Issuer symbol
BPMC
Transactions as of
06 Jun 2022
Net transactions value
-$114,022
Form type
4
Filing time
08 Jun 2022, 16:05:20 UTC
Previous filing
03 Mar 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Sale $114,022 -1,908 -6.2% $59.76 28,685 06 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.